Lataa...
In silico study of thymohydroquinone interaction with blood–brain barrier disrupting proteins
AIM: To evaluate the inhibitory interaction of thymohydroquinone against blood–brain barrier (BBB)-associated neuropsychiatric and neurodegenerative disorders. MATERIALS & METHODS: An elaborated in silico study was designed to evaluate the interaction of thymohydroquinone with BBB-disrupting pro...
Tallennettuna:
| Julkaisussa: | Future Sci OA |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Future Science Ltd
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7720366/ https://ncbi.nlm.nih.gov/pubmed/33312701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0115 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|